The Patent Finder

Terms ending in 2038

Crititech, Inc.

Every in-force patent on Crititech, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,737,972Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
In force
 · Medium confidence
Crititech, Inc.In forceMedium confidence
US 12,128,131Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
In force
 · Low confidence
Crititech, Inc.In forceLow confidence
US 10,398,646Methods for Treating Lung Disorders
In force
 · High confidence
Crititech, Inc.In forceHigh confidence
US 10,507,181Methods for Treating Lung Disorders
In force
 · High confidence
Crititech, Inc.In forceHigh confidence
US 11,160,754Methods for Treating Lung Disorders
In force
 · High confidence
Crititech, Inc.In forceHigh confidence
US 11,523,983Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
In force
 · Medium confidence
Crititech, Inc.In forceMedium confidence
US 11,104,663Ciprofloxacin Polymorph and Its Use
In force
 · High confidence
Crititech, Inc.In forceHigh confidence
US 11,918,691Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
In force
 · Medium confidence
Crititech, Inc.In forceMedium confidence
US 12,329,858Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
In force
 · Medium confidence
Crititech, Inc.In forceMedium confidence
US 11,058,639Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
In force
 · High confidence
Crititech, Inc.In forceHigh confidence
2 more term ends in 2038 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited